Trial intelligence / Profile preview

Low-dose dextroketamine effects on intraoperative brain monitoring

RBR-4vdpqrtPhase 4Completed

Sponsor
Hospital São Carlos
Start
Aug 2022
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial (2 arms), sponsored by Hospital São Carlos. Primary endpoints: Electroencephalographic changes after dextroketamine versus saline and Between-group and within-group EEG comparisons. Started Aug 2022; status: completed.

Beyond the preview

Go deeper on RBR-4vdpqrt.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4vdpqrt.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call